Last reviewed · How we verify

NCT07260786: SMILE LASEK

the Correlation Between Visual Quality After SMILE and LASEK in Patients With Moderate to Low Myopia

Completed Last updated 3 December 2025
What this trial tests

trial in Myopia in 100 participants. Completed in 31 December 2024.

Timeline
1 January 2022
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsoryuhao shao
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date1 January 2022
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across China

Conditions studied

Sponsor

yuhao shao

Who can join

Adults 18 to 50, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Study the changes in subjective visual quality, contrast sensitivity, and total ocular aberrations of patients with low-to-moderate myopia after SMILE and LASEK surgeries at different age groups; 2. Evaluate the effects of SMILE and LASEK surgeries on the visual conduction pathway PVEP in patients with refractive errors of different age groups; 3. Clarify the correlations between subjective and objective visual quality after SMILE and LASEK surgeries in patients with refractive errors of different age groups and PVEP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other yuhao shao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07260786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing